Effect of HIV-2 infection on HIV-1 disease progression.

Effect of HIV-2 infection on HIV-1 disease progression.

Bibliographic Details
Main Authors:	de Silva, T, Leligdowicz, A, Rowland-Jones, S
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection.
by: Leligdowicz, A, et al.
Published: (2008)

The protective effect of HIV-2 infection: implications for understanding HIV-1 immunity.
by: Kanki, P, et al.
Published: (2014)

HIV-1 transmission and acute HIV-1 infection.
by: Hansasuta, P, et al.
Published: (2001)

HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation
by: de Silva, T, et al.
Published: (2018)

Protective immunity against HIV infection: lessons from HIV-2 infection.
by: Rowland-Jones, S
Published: (2006)

Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?
by: Nyamweya, S, et al.
Published: (2012)

Two distinct epidemics: the rise of HIV-1 and decline of HIV-2 infection between 1990 and 2007 in rural Guinea-Bissau.
by: Tienen, C, et al.
Published: (2010)

Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis.
by: Nyamweya, S, et al.
Published: (2013)

Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis
by: Nyamweya, S, et al.
Published: (2013)

Long-term non-progression in HIV infection: clinico pathological issues.
by: Rowland-Jones, S
Published: (1999)

Correlates of delayed disease progression in HIV-1-infected Kenyan children.
by: Chakraborty, R, et al.
Published: (2005)

Resisting immune exhaustion in HIV-1 infection.
by: Sarah Rowland-Jones, et al.
Published: (2008-05-01)

Direct relationship between virus load and systemic immune activation in HIV-2 infection.
by: Leligdowicz, A, et al.
Published: (2010)

Direct relationship between virus load and systemic immune activation in HIV-2 infection
by: Leligdowicz, A, et al.
Published: (2010)

Correction: Resisting Immune Exhaustion in HIV-1 Infection.
by: Sarah Rowland-Jones, et al.
Published: (2008-06-01)

Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia.
by: Peterson, I, et al.
Published: (2011)

Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia
by: Peterson, I, et al.
Published: (2011)

Immune Mechanisms of Viral Control in HIV-2 Infection
by: Moysi, E, et al.
Published: (2012)

Delayed disease progression in HIV-2: the importance of TRIM5α and the retroviral capsid
by: Boswell, M, et al.
Published: (2019)

Novel agents for the treatment of HIV-2 infection.
by: Peterson, K, et al.
Published: (2012)

How does the humoral response to HIV-2 infection differ from HIV-1 and can this explain the distinct natural history of infection with these two human retroviruses?
by: Makvandi-Nejad, S, et al.
Published: (2014)

The role of chemokine receptors in HIV infection.
by: Rowland-Jones, S
Published: (1999)

Cytotoxic T lymphocytes in HIV infection
by: Rowland-Jones, S, et al.
Published: (1993)

Resisting immune exhaustion in HIV-1 infection (vol 5, pg e134, 2008)
by: Rowland-Jones, S, et al.
Published: (2008)

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.
by: Yindom, L, et al.
Published: (2010)

Highly avid, oligoclonal, early-differentiated antigen-specific CD8+ T cells in chronic HIV-2 infection.
by: Leligdowicz, A, et al.
Published: (2010)

Highly avid, oligoclonal, early-differentiated antigen-specific CD8 + T cells in chronic HIV-2 infection
by: Leligdowicz, A, et al.
Published: (2010)

An underestimated lentivirus model: what can HIV-2 research contribute to the development of an effective HIV-1 vaccine?
by: Hodges-Mameletzis, I, et al.
Published: (2011)

Comparison of Cytotoxic activity and Interferon-g secretion by Natural Killer Cells in HIV-1 and HIV-2 infected individuals
by: Whittle Hilton, et al.
Published: (2010-05-01)

Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings.
by: Peterson, K, et al.
Published: (2011)

Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection.
by: Duvall, MG, et al.
Published: (2006)

HIV-2: the forgotten AIDS virus.
by: de Silva, T, et al.
Published: (2008)

Survival with HIV infection: good luck or good breeding?
by: Rowland-Jones, S
Published: (1998)

HIV infection: where have all the T cells gone?
by: Rowland-Jones, S
Published: (1999)

Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?
by: Rowland-Jones, S, et al.
Published: (2007)

Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians.
by: Jobarteh, M, et al.
Published: (2010)

Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
by: Brown, M, et al.
Published: (2004)

Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection
by: Leligdowicz, A, et al.
Published: (2007)

Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.
by: Leligdowicz, A, et al.
Published: (2007)

Robust gag-specific T cell responses characterize viremia control in HIV-2 infection
by: Leligdowicz, A, et al.
Published: (2007)